BNP Paribas Financial Markets’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.61M | Sell |
64,569
-74,688
| -54% | -$4.51M | ﹤0.01% | 2007 |
|
|
2026
Q1 | $5.61M | Buy |
139,257
+111,631
| +404% | +$4.17M | ﹤0.01% | 1933 |
|
|
2025
Q4 | $961K | Sell |
27,626
-4,403
| -14% | -$346K | ﹤0.01% | 3139 |
|
|
2025
Q3 | $2.66M | Buy |
32,029
+4,253
| +15% | +$308K | ﹤0.01% | 2417 |
|
|
2025
Q2 | $2.04M | Sell |
27,776
-45,785
| -62% | -$3.32M | ﹤0.01% | 2457 |
|
|
2025
Q1 | $8.4M | Buy |
73,561
+15,731
| +27% | +$957K | ﹤0.01% | 1502 |
|
|
2024
Q4 | $2.91M | Sell |
57,830
-42,258
| -42% | -$2.21M | ﹤0.01% | 2143 |
|
|
2024
Q3 | $4.63M | Sell |
100,088
-87,846
| -47% | -$3.12M | ﹤0.01% | 1546 |
|
|
2024
Q2 | $6.11M | Sell |
187,934
-23,658
| -11% | -$648K | 0.01% | 1322 |
|
|
2024
Q1 | $5.33M | Buy |
211,592
+140,815
| +199% | +$3.33M | ﹤0.01% | 1420 |
|
|
2023
Q4 | $2.3M | Sell |
70,777
-20,768
| -23% | -$570K | ﹤0.01% | 1872 |
|
|
2023
Q3 | $2.49M | Buy |
91,545
+69,905
| +323% | +$2.02M | ﹤0.01% | 1737 |
|
|
2023
Q2 | $481K | Sell |
21,640
-34,678
| -62% | -$798K | ﹤0.01% | 2603 |
|
|
2023
Q1 | $1.22M | Buy |
56,318
+37,859
| +205% | +$830K | ﹤0.01% | 2181 |
|
|
2022
Q4 | $375K | Sell |
18,459
-25,398
| -58% | -$637K | ﹤0.01% | 2730 |
|
|
2022
Q3 | $1.12M | Buy |
43,857
+19,187
| +78% | +$513K | ﹤0.01% | 2396 |
|
|
2022
Q2 | $587K | Sell |
24,670
-10,198
| -29% | -$222K | ﹤0.01% | 2572 |
|
|
2022
Q1 | $785K | Sell |
34,868
-5,200
| -13% | -$111K | ﹤0.01% | 2478 |
|
|
2021
Q4 | $793K | Sell |
40,068
-58,957
| -60% | -$1.2M | ﹤0.01% | 2748 |
|
|
2021
Q3 | $1.95M | Buy |
99,025
+57,737
| +140% | +$1.21M | ﹤0.01% | 1919 |
|
|
2021
Q2 | $908K | Buy |
41,288
+9,286
| +29% | +$207K | ﹤0.01% | 2242 |
|
|
2021
Q1 | $761K | Sell |
32,002
-652
| -2% | -$17.4K | ﹤0.01% | 2314 |
|
|
2020
Q4 | $854K | Sell |
32,654
-1,996
| -6% | -$42.1K | ﹤0.01% | 2125 |
|
|
2020
Q3 | $603K | Buy |
34,650
+18,323
| +112% | +$292K | ﹤0.01% | 2102 |
|
|
2020
Q2 | $275K | Sell |
16,327
-41,638
| -72% | -$585K | ﹤0.01% | 2365 |
|
|
2020
Q1 | $689K | Buy |
57,965
+32,803
| +130% | +$406K | ﹤0.01% | 2174 |
|
|
2019
Q4 | $304K | Buy |
25,162
+7,533
| +43% | +$105K | ﹤0.01% | 2757 |
|
|
2019
Q3 | $249K | Sell |
17,629
-31,187
| -64% | -$383K | ﹤0.01% | 2635 |
|
|
2019
Q2 | $544K | Buy |
48,816
+26,265
| +116% | +$293K | ﹤0.01% | 1960 |
|
|
2019
Q1 | $265K | Buy |
22,551
+20,297
| +900% | +$252K | ﹤0.01% | 2520 |
|
|
2018
Q4 | $30.1K | Sell |
2,254
-3,207
| -59% | -$42.4K | ﹤0.01% | 2960 |
|
|
2018
Q3 | $76.6K | Buy |
5,461
+492
| +10% | +$6.88K | ﹤0.01% | 2883 |
|
|
2018
Q2 | $78.1K | Sell |
4,969
-25,154
| -84% | -$438K | ﹤0.01% | 2914 |
|
|
2018
Q1 | $496K | Sell |
30,123
-8,461
| -22% | -$157K | ﹤0.01% | 2217 |
|
|
2017
Q4 | $697K | Buy |
38,584
+29,420
| +321% | +$533K | ﹤0.01% | 2233 |
|
|
2017
Q3 | $177K | Sell |
9,164
-543
| -6% | -$8.1K | ﹤0.01% | 2520 |
|
|
2017
Q2 | $115K | Buy |
9,707
+9,388
| +2,943% | +$102K | ﹤0.01% | 2755 |
|
|
2017
Q1 | $3.5K | Sell |
319
-834
| -72% | -$7.33K | ﹤0.01% | 3390 |
|
|
2016
Q4 | $8.37K | Sell |
1,153
-3,897
| -77% | -$30.5K | ﹤0.01% | 3528 |
|
|
2016
Q3 | $32.8K | Buy |
5,050
+2,147
| +74% | +$12.5K | ﹤0.01% | 2630 |
|
|
2016
Q2 | $15.8K | Buy |
+2,903
| New | +$15.1K | ﹤0.01% | 2690 |
|
|
2016
Q1 | – | Sell |
-5,740
| Closed | -$28.6K | – | 2746 |
|
|
2015
Q4 | $28.6K | Sell |
5,740
-6,791
| -54% | -$30.6K | ﹤0.01% | 2674 |
|
|
2015
Q3 | $47.1K | Buy |
12,531
+7,382
| +143% | +$37.5K | ﹤0.01% | 2910 |
|
|
2015
Q2 | $30.9K | Buy |
5,149
+3,896
| +311% | +$23.9K | ﹤0.01% | 2776 |
|
|
2015
Q1 | $7.02K | Buy |
+1,253
| New | +$4.54K | ﹤0.01% | 2958 |
|
|
2014
Q4 | – | Sell |
-3,112
| Closed | -$8.34K | – | 2224 |
|
|
2014
Q3 | $8.34K | Buy |
3,112
+2,738
| +732% | +$7.25K | ﹤0.01% | 3668 |
|
|
2014
Q2 | $1.05K | Buy |
+374
| New | +$1.1K | ﹤0.01% | 3417 |
|
|
2014
Q1 | – | Sell |
-689
| Closed | -$2.22K | – | 3467 |
|
|
2013
Q4 | $2.22K | Sell |
689
-14,166
| -95% | -$28.6K | ﹤0.01% | 3614 |
|
|
2013
Q3 | $23.6K | Sell |
14,855
-8,534
| -36% | -$15K | ﹤0.01% | 2558 |
|
|
2013
Q2 | $40.5K | Buy |
+23,389
| New | +$42K | ﹤0.01% | 2697 |
|
Other funds holding CORT
ISL
PA
BNP Paribas Financial Markets's CORT Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Corcept Therapeutics (CORT) stake by 54% in Q2 2026, selling an estimated $4.51M and leaving 64,569 shares worth $5.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2007.
BNP Paribas Financial Markets first reported a position in CORT in Q2 2013 and has held it in 50 quarters since. The position peaked at $8.4M in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- BNP Paribas Financial Markets held 64,569 shares of Corcept Therapeutics worth $5.61M as of Q2 2026.
- BNP Paribas Financial Markets sold 74,688 Corcept Therapeutics shares in Q2 2026, an estimated $4.51M.
- Corcept Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2007 holding.
- BNP Paribas Financial Markets first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 50 quarters since.
- BNP Paribas Financial Markets's Corcept Therapeutics position peaked at $8.4M in Q1 2025.
- 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.